| Literature DB >> 25279832 |
Jesús de Pedro-Cuesta1, Ignacio Mahillo-Fernandez1, Miguel Calero2, Alberto Rábano3, Mabel Cruz4, Åke Siden4, Pablo Martínez-Martín1, Henning Laursen5, María Ruiz-Tovar1, Kåre Mølbak6.
Abstract
INTRODUCTION: Sporadic Creutzfeldt-Jakob disease (sCJD) might be transmitted by surgery. The purpose of this study was to investigate potential susceptibility to sCJD from surgery at juvenile age and in early adulthood.Entities:
Mesh:
Year: 2014 PMID: 25279832 PMCID: PMC4184848 DOI: 10.1371/journal.pone.0109412
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Associations for surgical procedures predating the time point of clinical onset in cases or the corresponding index date in controls by ≥20 years.
| Model | Exposure level | Age (years) at first-registered SP | Subject | n | % | OR | (95% CI) |
|
| Unexposed | All ages | Cases | 134 | (80.2) | - | - |
| MCs | 745 | (89.2) | - | - | |||
| Exposed to main SPs | All ages | Cases | 32 | (19.2) | - | - | |
| MCs | 89 | (10.7) | 2.44 | (1.46–4.07) | |||
| Exposed to subsidiary SPs | All ages | Cases | 1 | (0.6) | - | - | |
| MCs | 1 | (0.1) | 6.82 | (0.41–113) | |||
|
| Unexposed | All ages | Cases | 134 | (80.2) | - | - |
| MCs | 745 | (89.2) | - | - | |||
| Exposed to main SPs | Mean 26.0, range 17.3–29.5 | Cases | 7 | (4.2) | - | - | |
| MCs | 11 | (1.3) | 12.8 | (2.56–64.00) | |||
| Mean 35.5, range 30.7–40.0 | Cases | 8 | (4.8) | - | - | ||
| MCs | 21 | (2.5) | 3.04 | (1.26–7.33) | |||
| Mean 49.9, range 40.0–62.0 | Cases | 17 | (10.2) | - | - | ||
| MCs | 57 | (6.8) | 1.75 | (0.89–3.45) | |||
| Exposed to subsidiary SPs | All ages | Cases | 1 | (0.6) | - | - | |
| MCs | 1 | (0.1) | 7.46 | (0.23–242) | |||
|
| Unexposed | All ages | Cases | 134 | (80.2) | - | - |
| MCs | 745 | (89.2) | - | ||||
| Exposed to HR or LR SPs | All ages | Cases | 25 | (15.0) | - | - | |
| MCs | 58 | (7.0) | 2.81 | (1.62–4.88) | |||
| Exposed to other risk SPs | All ages | Cases | 8 | (4.8) | - | - | |
| MCs | 32 | (3.8) | 1.74 | (0.76–3.95) | |||
|
| Unexposed | All ages | Cases | 134 | (80.2) | - | - |
| MCs | 745 | (89.2) | - | - | |||
| Exposed to HR or LR SPs | Mean 26.4, range 23.9–29.5 | Cases | 5 | (3.0) | - | - | |
| MCs | 6 | (0.8) | 13.20 | (2.47–70.50) | |||
| Mean 36.0, range 30.9–39.8 | Cases | 6 | (3.6) | - | - | ||
| MCs | 12 | (1.4) | 3.57 | (1.26–10.10) | |||
| Mean 50.0, range 40.0–62.0 | Cases | 14 | (8.4) | - | - | ||
| MCs | 40 | (4.8) | 2.10 | (1.05–4.17) | |||
| Exposed to Other risk SPs | All ages | Cases | 8 | (4.8) | - | ||
| MCs | 32 | (3.8) | 1.79 | (0.78–4.09) |
Models 1 and 2, anatomic SP classification; models 3 and 4, etiologic SP classification. Other risk SPs encompass three reported etiologic SP categories, i.e., lowest-risk, no-risk, and not reclassified [7]. Age subcategories <30, 30–39, and ≥40 years at first-registered surgery.
Subsidiary procedures' is a heterogeneous category that includes minor surgery (punctures, needle aspiration or biopsy, superficial incisions), other non-surgical, potentially invasive procedures, such as transluminal endoscopies (with or without biopsy), and, in a few instances in Denmark, blood transfusion.
SP-code distribution by body system groups in exposed cases.
n = 15. Female genital organs and obstetric SP, 7; Digestive system and spleen, 3; Other groups, 5.
n = 15. Female genital organs and obstetric SP, 8; Digestive system and spleen, 3, Other groups, 4.
n = 37. Female genital organs and obstetric SP, 18; Digestive system and spleen, 8; Peripheral vessels and lymphatic system, 5; Other groups, 6.
HR or LR SPs: acronym for higher-risk or lower-risk SPs [7].
Figure 1Potential age-at-exposure-related susceptibility for the following different CJD forms and exposures:
(a) Age-susceptibility function for vCJD in the UK [12], and results from Table 1 for risk of sCJD from age at first hospital discharge associated with a registered, main surgical procedure, at a lag of ≥20 years. (b) Reported estimated risks relating to 5- to 10-year age groups, after adjustment for dietary exposure to bovine material and average incubation period established at 12.6 years for variant CJD in the UK [13], and plotted results from Table 1 for risk of sCJD from age at first hospital discharge associated with an etiologically reclassified higher-risk or lower-risk procedure, at a lag of ≥20 years. (c) Reported rate ratios of accidentally transmitted CJD (iCJD), for ever treatement vs never treatement with pituitary growth hormone (all treatments) at specific ages [11]. Reference: all other ages at treatment. (d) Reported rate ratios of accidentally transmitted CJD (iCJD) for ever treatment vs never treatment with pituitary growth hormone processed with the Hartree-modified Wilhelmi method (an hGH preparation associated with highest risk of iCJD among hGH-treated cohorts) at specific ages [11]. Reference: all other ages at treatment.